Sort
30,917 grants matching “tumor microenvironment”
(PQA2) Interstitial stiffness as a physicochemical modulator of obesity-induced b
$329,112Claudia Fischbach · Cornell University · R01 · FY2016 · CA
(PQA2) Interstitial stiffness as a physicochemical modulator of obesity-induced b
$329,104Claudia Fischbach · Cornell University · R01 · FY2017 · CA
Project 2 Intrathecal Anti-PD-1 Immunotherapy for Metastatic Melanoma Patients with Leptomeningeal Disease (LMD)
$329,063Jennifer A. Wargo · University Of Tx Md Anderson Can Ctr · P50 · FY2020 · CA
Targeting mechanosignaling in pediatric brain cancer
$329,013Sigrid A Langhans · Nemours Children'S Hospital, Delaware · R01 · FY2025 · CA
Biology of Melanoma Metastasis
$329,003Meenhard Herlyn · Wistar Institute · R01 · FY2015 · CA
HTS Assays for Targeting the cGAS-STING Pathway in Autoimmune Diseases and Cancer
$328,984Robert G Lowery · Bellbrook Labs, Llc · R44 · FY2019 · GM
Chimeric Switch Receptors to Potentiate CAR T Cell Therapy for Solid Tumor Cancers
$328,946Anthony Cooper · Javelin Oncology, Inc. · R43 · FY2022 · CA
Project 1: Tumor Cell Intrinsic Determinants of Early Dissemination in Melanoma
$328,933Eva Hernando · New York University School Of Medicine · U54 · FY2022 · CA
Targeting Glioblastoma Cells and Tumor Microenvironment with CAR-T Cell Therapy
$328,895Yvonne Yu-Hsuan Chen · University Of California Los Angeles · P50 · FY2025 · CA
Internalizing human antibody-targeted nanosized siRNA therapeutics
$328,888Bin Liu · University Of California, San Francisco · R01 · FY2016 · CA
(PQC4) Fate of cells disseminating from human breast cancer xenografts
$328,888Zena Werb · University Of California, San Francisco · R01 · FY2015 · CA
Investigating Breast Cancer Collective Invasion
$328,888Gray W Pearson · Ut Southwestern Medical Center · R01 · FY2011 · CA
(PQC4) Fate of cells disseminating from human breast cancer xenografts
$328,888Zena Werb · University Of California, San Francisco · R01 · FY2016 · CA
Stromal Fibroblast Autophagy In Tumor Progression and Desmoplasia
$328,888Jayanta Debnath · University Of California, San Francisco · R01 · FY2020 · CA
Targeting macrophages to sensitize myeloma to immune checkpoint blockade
$328,888Qing Yi · Cleveland Clinic Lerner Com-Cwru · R01 · FY2017 · CA
Stromal Fibroblast Autophagy In Tumor Progression and Desmoplasia
$328,888Jayanta Debnath · University Of California, San Francisco · R01 · FY2021 · CA
Targeting macrophages to sensitize myeloma to immune checkpoint blockade
$328,888Qing Yi · Cleveland Clinic Lerner Com-Cwru · R01 · FY2018 · CA
Stromal Fibroblast Autophagy In Tumor Progression and Desmoplasia
$328,888Jayanta Debnath · University Of California, San Francisco · R01 · FY2018 · CA
Internalizing human antibody-targeted nanosized siRNA therapeutics
$328,888Bin Liu · University Of California, San Francisco · R01 · FY2015 · CA
Role of MYC-MIZ1 signaling and the inflammatory immune microenvironment in Triple-Negative Breast Cancer Racial Disparities
$328,822Vinay Varadan · Case Western Reserve University · P20 · FY2019 · CA
Development of novel metastatic mouse models that recapitulate the major immune contexts of human colon cancer
$328,798Tyler E Jacks · Massachusetts Institute Of Technology · R01 · FY2021 · CA
Mechanisms promoting translocations and mature B cell lymphomas
$328,781Jing Hong Wang · University Of Colorado Denver · R01 · FY2012 · CA
6-thio-2'-deoxyguanosine in GBM: Pre-clinical Evaluation of Mechanism of action, Efficacy and Biomarker identification
$328,761David M. Ashley · Duke University · U19 · FY2023 · CA
Innate and Adaptive Anti-Myeloma Immunity
$328,732Nikhil C. Munshi · Dana-Farber Cancer Inst · P01 · FY2013 · CA
Cytokine regulation of RA synoviocyte phenotype
$328,690Lionel B Ivashkiv · Hospital For Special Surgery · R01 · FY2006 · AR